HOLX
May 1, 2023 - AI Summary
Undervalued by 34.6% based on the discounted cash flow analysis.
Market cap | $17.68 Billion |
---|---|
Enterprise Value | $18.07 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $1.92 |
Beta | 0.51 |
Outstanding Shares | 233,376,948 |
Avg 30 Day Volume | 1,454,455 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 37.9 |
---|---|
PEG | -170.37 |
Price to Sales | 4.7 |
Price to Book Ratio | 3.76 |
Enterprise Value to Revenue | 4.56 |
Enterprise Value to EBIT | 20.39 |
Enterprise Value to Net Income | 38 |
Total Debt to Enterprise | 0.14 |
Debt to Equity | 0.53 |
No data
No data
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.